REUTERS: Anthera Pharmaceuticals Inc said on Tuesday that its drug to treat certain cystic fibrosis patients failed a late-stage study, sending the company’s shares tumbling nearly 70 percent in after-hours trading. The latest setback for Anthera comes just over a month after the company said an experimental drug to treat lupus had also failed in a late-stage study.